A multi-center, phase 1b study to assess the safety, Pharmacokinetics and efficacy of subcutaneous Isatuximab plus Pomalidomide and Dexamethasone, in patients with Relapsed/Refractory Multiple Myeloma

Authors :: Moreau, P
Parmar, G
Prince, M
Ocio, E
Karenes, C
Madan, S
Oriol, A
Bories, P
Delforge, M
Galbrail, N
Semiond, D
Jia, N
Mace, S
Suzan, F
van de Velde, H
Source :: Clinical Lymphoma Myeloma & Leukemia, r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol, instname
Publication Year :: 2021
Publisher :: Cancer Media Group, 2021.

ISSN :: 21522650
Database :: OpenAIRE
Journal :: Clinical Lymphoma Myeloma & Leukemia, r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol, instname
Accession number :: edsair.RECOLECTA.....925c8e20bcc4f39c8f7f88b5db1f392d

Tools